These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21693154)

  • 41. Global down-regulation of gene expression in the brain using RNA interference, with emphasis on monoamine transporters and GPCRs: implications for target characterization in psychiatric and neurological disorders.
    Hoyer D; Thakker DR; Natt F; Maier R; Huesken D; Müller M; Flor P; VAN DER Putten H; Schmutz M; Bilbe G; Cryan JF
    J Recept Signal Transduct Res; 2006; 26(5-6):527-47. PubMed ID: 17118797
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of Paroxetine Molecular Interactions with Selected Monoamine and γ-Aminobutyric Acid Transporters.
    Kowalska M; Fijałkowski Ł; Nowaczyk A
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208199
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced cognitive flexibility and phasic striatal dopamine dynamics in a mouse model of low striatal tonic dopamine.
    Delaney J; Nathani S; Tan V; Chavez C; Orr A; Paek J; Faraji M; Setlow B; Urs NM
    Neuropsychopharmacology; 2024 Sep; 49(10):1600-1608. PubMed ID: 38698264
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic Social Defeat During Adolescence Induces Short- and Long-Term Behavioral and Neuroendocrine Effects in Male Swiss-Webster Mice.
    Mancha-Gutiérrez HM; Estrada-Camarena E; Mayagoitia-Novales L; López-Pacheco E; López-Rubalcava C
    Front Behav Neurosci; 2021; 15():734054. PubMed ID: 34658806
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential Regulation of Adhesion and Phagocytosis of Resting and Activated Microglia by Dopamine.
    Fan Y; Chen Z; Pathak JL; Carneiro AMD; Chung CY
    Front Cell Neurosci; 2018; 12():309. PubMed ID: 30254570
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Constitutive plasma membrane monoamine transporter (PMAT, Slc29a4) deficiency subtly affects anxiety-like and coping behaviours.
    Gilman TL; George CM; Vitela M; Herrera-Rosales M; Basiouny MS; Koek W; Daws LC
    Eur J Neurosci; 2018 May; ():. PubMed ID: 29797618
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Organic cation transporter 3 contributes to norepinephrine uptake into perivascular adipose tissue.
    Ayala-Lopez N; Jackson WF; Burnett R; Wilson JN; Thompson JM; Watts SW
    Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1904-14. PubMed ID: 26432838
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased antidepressant sensitivity after prefrontal cortex glucocorticoid receptor gene deletion in mice.
    Hussain RJ; Jacobson L
    Physiol Behav; 2015 Jan; 138():113-7. PubMed ID: 25447332
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Norepinephrine transporter heterozygous knockout mice exhibit altered transport and behavior.
    Fentress HM; Klar R; Krueger JJ; Sabb T; Redmon SN; Wallace NM; Shirey-Rice JK; Hahn MK
    Genes Brain Behav; 2013 Nov; 12(8):749-59. PubMed ID: 24102798
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antidepressant activity: contribution of brain microdialysis in knock-out mice to the understanding of BDNF/5-HT transporter/5-HT autoreceptor interactions.
    Gardier AM
    Front Pharmacol; 2013; 4():98. PubMed ID: 23964240
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Altered reward circuitry in the norepinephrine transporter knockout mouse.
    Gallagher JJ; Zhang X; Hall FS; Uhl GR; Bearer EL; Jacobs RE
    PLoS One; 2013; 8(3):e57597. PubMed ID: 23469209
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters.
    Zhang S; Fernandez F; Hazeldine S; Deschamps J; Zhen J; Reith ME; Dutta AK
    J Med Chem; 2006 Jul; 49(14):4239-47. PubMed ID: 16821783
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters.
    Haenisch B; Bönisch H
    Pharmacol Ther; 2011 Mar; 129(3):352-68. PubMed ID: 21147164
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
    Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
    Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Norepinephrine transporter (NET) knock-out upregulates dopamine and serotonin transporters in the mouse brain.
    Solich J; Faron-Gorecka A; Kusmider M; Palach P; Gaska M; Dziedzicka-Wasylewska M
    Neurochem Int; 2011 Aug; 59(2):185-91. PubMed ID: 21693154
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Norepinephrine transporter knockout-induced up-regulation of brain alpha2A/C-adrenergic receptors.
    Gilsbach R; Faron-Górecka A; Rogóz Z; Brüss M; Caron MG; Dziedzicka-Wasylewska M; Bönisch H
    J Neurochem; 2006 Feb; 96(4):1111-20. PubMed ID: 16417582
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Studies of the biogenic amine transporters. 10. Characterization of a novel cocaine binding site in brain membranes prepared from dopamine transporter knockout mice.
    Rothman RB; Carroll FI; Morales M; Rowley DL; Rice KC; Dersch CM; Donovan DM
    Synapse; 2002 May; 44(2):94-105. PubMed ID: 11891881
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.